Patients with Kawasaki disease can develop heart complications such as mild dilatation of the coronary arteries. These abnormalities, usually diagnosed in the first two weeks of the illness, are likely to resolve spontaneously within a few weeks or months.
However, some patients may suffer from more serious complications such as coronary aneurysm, which can result in further heart problems.
“Coronary aneurysm can lead to coronary insufficiency due to blockage, decreased cardiac function (weak heart), abnormal heart rhythms or sudden death,” he added.
Other potential heart complications, though less common, include acute myocarditis (inflammation of the heart muscle), valve leakage, pericardial effusion, arrhythmias (abnormal heart rhythms) and acute myocardial infarction.
“Children who are younger, who show atypical presentation of Kawasaki disease, who are resistant to intravenous immunoglobulins, or those who have had recurrent Kawasaki disease, will have a higher risk of developing heart problems,” says A/Prof Tan.
Treatment for Kawasaki disease
Kawasaki disease treatment generally entails hospitalisation for 3-7 days. The mainstay of treatment of Kawasaki disease is intravenous immunoglobulin (IVIG), to help reduce the risk of heart problems.
Aspirin is also used as an adjunct treatment -- high doses of aspirin are given in the acute phase, and converted to low, once-a-day doses later in the subacute phase of the disease.
After Kawasaki disease treatment, the patient will require follow-up heart ultrasound scans (echocardiograms) to ensure there are no complications from the disease.
What is the Kawasaki disease?
Kawasaki disease is a childhood illness that typically affects children below the age of 5. It can also affect older children but this is not common.
In Kawasaki disease, also known as mucocutaneous lymph node syndrome, small- and medium-sized arteries in different parts of the body get inflamed. Lymph nodes are also affected.
Kawasaki disease: Causes and risk factors
The cause of Kawasaki disease is unknown though doctors believe the inflammation could be due to the body’s overreaction to a viral or bacterial infection. Most patients have a complete recovery and go on to lead normal and healthy lives.
“The incidence of Kawasaki disease in Singapore is estimated at 51.4 per 100,000 children ≤ 5 years of age,” says A/Prof Tan.
“KKH sees an average of 120 new cases per year of which about half are below the age of 21. The younger the age group, the higher the incidence, and more than 90 per cent of our patients with Kawasaki disease are 5 years old or younger,” adds A/Prof Tan.
Age is not the only risk factor for Kawasaki disease. Asians have been found to be more prone to this inflammatory disease than Caucasians.
Among Asian countries, Japan has a higher incidence than countries such as China and Taiwan, which have a rate similar to Singapore. The incidence of Kawasaki disease in Japan is above 200 per 100,000 children ≤ 5 years of age while in the USA, it is 19.6 and in Australia it is 5.5 per 100,000 children ≤ 5 years of age.
Kawasaki disease is named after the Japanese doctor Tomisaku Kawasaki who first described the disease in 1967.
Symptoms of Kawasaki disease
A diagnosis of Kawasaki disease is mainly based on the following clinical signs and symptoms:
High fever for at least 5 days
Red eyes (conjunctivitis)
Red, cracked lips and red-coloured, swollen tongue
Swollen lymph nodes in the neck
Swollen and red palms of hands and soles of feet, peeling of the skin of the extremities can occur later
Other symptoms include abdominal pain, joint pain, diarrhoea and vomiting. At a later stage of the illness, the patient may present skin peeling on the toes and fingers, especially at the tips.
Symptoms of Kawasaki disease will usually resolve with treatment or with time. However, in some patients, complications, especially those related to the heart, may develop.